Grant Review Committee 2022-2023

Organizational Affiliations and Titles are included to identify individuals, however, all individuals listed serve in a personal capacity, and not as a representative of the organization to which they are employed.

Ana Carrizosa Anderson, PhD — Chair

Associate Professor, Neurology
Harvard Medical School
Associate Scientist, Neurology
Brigham and Women’s Hospital

Andrew Aplin, PhD

Associate Director, Basic Research
Program Leader, Cancer Cell Biology &
Signaling, NCI-designated Sidney Kimmel Cancer Center
Professor, Department of Cancer Biology
Thomas Jefferson University

Boris Bastian, MD, PhD

Professor, Dermatology and Pathology
Gerson and Barbara Bass Bakar Distinguished
Professor, Cancer Research
University of California, San Francisco

Emily Bernstein, PhD

Co-leader of the Cancer Mechanisms Research Program
The Tisch Cancer Institute
Professor, Oncological Sciences
Professor, Dermatology
Ichan School of Medicine at Mount Sinai

Nina Bhardwaj, MD, PhD

Professor of Medicine and Urology
Director of Immunotherapy
Medical Director of the Vaccine and Cell
Therapy Laboratory
Co-Director of the Cancer Immunology
Program, The Tisch Cancer Institute
Icahn School of Medicine at Mount Sinai

Marcus Bosenberg, MD, PhD

Professor of Dermatology, Pathology, and
Co-Leader, Genetics, Genomics and Epigenetics, Yale Cancer Center
Director, Yale Center for Immuno-Oncology
Director, Yale SPORE in Skin Cancer
Yale School of Medicine

Richard Carvajal, MD

Deputy Physician-in-Chief
Director of Medical Oncology
Northwell Health Cancer Institute
R.J. Zuckerberg Chair in Medical Oncology
Professor of Medicine
Donald and Barbara Zucker School of Medicine at Hofstra/Northwell

Paul Chapman, MD

Attending Physician, Melanoma and
Immunotherapeutics Service
Professor of Medicine, Weill Cornell Medical College
Memorial Sloan Kettering Cancer Center

Stephanie Dougan, PhD

Principal Investigator, Cancer Immunology and Virology
Associate Professor of Immunology, Harvard
Medical School
Dana-Farber Cancer Institute

David Fisher, MD, PhD

Chief, Dermatology Service
Director, Melanoma Program, MGH Cancer Center
Director, Cutaneous Biology Research Center
Massachusetts General Hospital

Keith Flaherty, MD

Professor, Medicine
Harvard Medical School
Co-Leader, Developmental Therapeutics
Dana-Farber / Harvard Cancer Center
Director, Henri and Belinda Termeer Center
for Targeted Therapies, Cancer Center
Director, Clinical Research, Cancer Center
Massachusetts General Hospital

Thomas Gajewski, MD, PhD

AbbVie Foundation Professor of Pathology
Professor, Ben May Department of Cancer Research
Professor, Medicine, University of Chicago

Jeffrey Gershenwald, MD — Co-Chair

Medical Director, Melanoma and Skin Center
Professor, Department of Surgical Oncology
The University of Texas MD Anderson
Cancer Center

Tanja de Gruijl, PhD

Professor, Medical Oncology Laboratory
Professor, Amsterdam Infection and Immunity — Cancer Immunology
Professor, Cancer Center Amsterdam — Cancer Biology and Immunology, Imaging and Biomarkers
Vrije Universiteit, Amsterdam

J. William Harbour, MD

Professor, Ophthalmology, Biochemistry and
Molecular Biology
Mark J. Daily Chair, Ophthalmology,
Vice Chairman, Translational Research
Director, Ocular Oncology
Eye Cancer Site Disease Group Leader
Associate Director, Basic Research, Sylvester Comprehensive Cancer Center
Bascom Palmer Eye Institute, University of Miami

Eva M. Hernando-Monge, PhD

Professor, Department of Pathology
New York University Langone Health

Thomas Hornyak, MD, PhD

Chief, Dermatology
Associate Chief of Staff, Research & Development
VA Maryland Health Care System
Associate Professor, Dermatology and Biochemistry and Molecular Biology
University of Maryland School of Medicine

Roger Lo, MD, PhD

Director, Melanoma Clinic in Dermatology
Director, Dermatology STAR Residency Program
Professor, Medicine
Associate Chief and Professor, Dermatology
Professor, Molecular & Medical Pharmacology
University of California, Los Angeles, David Geffen School of Medicine

David Lombard, MD, PhD

Department of Pathology & Laboratory Medicine
Co-Leader, Cancer Epigenetics Program
Sylvester Comprehensive Cancer Center
Miller School of Medicine

Michal Lotem, MD

Head, Center for Melanoma and Cancer
Immunotherapy, Dept of Oncology
Hadassah Hebrew University Medical Center

Glenn Merlino, PhD

Senior Investigator, Laboratory of Cancer
Biology and Genetics
Head, Cancer Modeling Section
Scientific Director for Basic Research, CCR
National Cancer Institute

Poulikos Poulikakos, PhD

Associate Professor, Department of Oncological Sciences
Icahn School of Medicine at Mount Sinai
Precision Immunology Institute
The Tisch Cancer Institute

Antoni Ribas, MD, PhD

Professor of Medicine, Surgery, Molecular and Medical Pharmacology
Director, Tumor Immunology Program, Jonsson
Comprehensive Cancer Center
Director, Parker Institute for Cancer
Immunotherapy Center at UCLA
University of California Los Angeles

Allison Betof Warner, MD, PhD — Stanford University

Caroline Robert, MD, PhD

Head, Dermatology Unit
Co-Director, Melanoma Research Unit
Professor, Dermatology
Institute Gustave Roussy

Jonathan Simons, MD

Chief Science Officer
Medical Director
The Marcus Foundation

Craig Slingluff, MD

Joseph Helms Farrow Professor, Surgery
Vice Chair, Research, Department of Surgery
Director, UVA Cancer Center Human Immune Therapy Center
Co-Chair, Melanoma Committee of ECOG
The University of Virginia

Marisol Soengas, PhD

Dean for Academic Affairs
Spanish National Cancer Research Center

David Solit, MD

Geoffrey Beene Chair
Director, Marie-Josée & Henry R. Kravis Center
for Molecular Oncology
Memorial Sloan Kettering Cancer Center

Susan Swetter, MD

Professor, Dermatology
Director, Pigmented Lesion & Melanoma Program
Physician Leader, Cancer Care Program in Cutaneous Oncology
Stanford University Medical Center & Cancer Institute

Jennifer Wargo, MD, MMSc

Professor, Genomic Medicine
Professor, Surgical Oncology
The University of Texas MD Anderson Cancer Center

Jeffrey S. Weber, MD, PhD

Deputy Director, Perlmutter Cancer Center
Co-Director, Melanoma Research Program
Laura and Isaac Perlmutter Professor of Oncology, Department of Medicine
NYU Grossman School of Medicine

Xu Wu, PhD

Principal Investigator, Cutaneous Biology Research
Center, Massachusetts General Hospital
Associate Professor, Dermatology, Harvard Medical School
Affiliate Faculty, Harvard Stem Cell Institute

Kai Wucherpfennig, MD, PhD

Chair, Cancer Immunology and Virology
Director, Center for Cancer Immunotherapy Research
Dana-Farber Cancer Institute
Professor, Neurology, Brigham and Women’s Hospital and Harvard Medical School
Associate Member, Broad Institute of MIT and Harvard

Iwei Yeh, MD, PhD

Associate Professor, Dermatology and Pathology
University of California, San Francisco


Charlotte Ariyan, MD, PhD — Memorial Sloan Kettering Cancer Center & Chris Carr — Acral Melanoma Patient Advocate


Daisy Helman – MRA Board of Directors and Co-Chair of MRA’s Dermatology Council